FFT Wealth Management LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

FFT Wealth Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,456 shares of the healthcare conglomerate’s stock after acquiring an additional 168 shares during the quarter. FFT Wealth Management LLC’s holdings in UnitedHealth Group were worth $736,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the third quarter valued at about $37,000. DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the 3rd quarter worth approximately $57,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 1.9 %

Shares of UNH stock opened at $470.49 on Wednesday. The company has a market cap of $432.99 billion, a price-to-earnings ratio of 30.35, a PEG ratio of 1.37 and a beta of 0.61. The stock has a 50 day simple moving average of $518.22 and a 200-day simple moving average of $559.08. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the company earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.79%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.